← Back to Search

Adaptive Attention Training for Healthy Adolescents

N/A
Waitlist Available
Led By Courtney Gallen, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention.
Awards & highlights

Study Summary

This trial will test a new attention training method to see if it improves cognitive function in healthy adolescents.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Test of Variables of Attention (TOVA), visual form, change from baseline
Secondary outcome measures
Delay Discounting task, change from baseline
Other outcome measures
Adaptive Cognitive Evaluation (ACE) neuropsychological battery, change from baseline
Attend Ignore Distractor (AID) task, change from baseline
Child Self-Control Rating Scale (parent and teacher ratings), change from baseline
+11 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Adaptive Attention TrainingExperimental Treatment1 Intervention
The training group will engage in 15 hours of at-home training on a novel iPad-based adaptive attention training program ('Engage'). Individuals will complete thirty 30-minute sessions over six weeks. Training compliance and performance data (accuracies and reaction times) will be continuously monitored remotely and analyzed over secure online servers to ensure that participants are completing training as scheduled and to deal with any unexpected road-blocks in training.
Group II: Active ControlPlacebo Group1 Intervention
The active control group will engage in 15 hours of at-home training on an iPad game ('Boing'). Individuals will complete game play for the same number of hours as the training group to control for the effects of computer exposure and interaction, contact with research personnel, and monetary rewards. Compliance will be monitored similarly to the adaptive attention training group.
Group III: Low-dose Adaptive Attention TrainingPlacebo Group1 Intervention
The low-dose training group will engage in 1 hour of at-home training on 'Engage'. Individuals will complete two 30-minute sessions at the beginning and middle of a six-week period. Compliance will be monitored similarly to the adaptive attention training group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Adaptive Attention Training
2019
N/A
~60

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,498 Previous Clinical Trials
11,936,288 Total Patients Enrolled
Alliance for Decision EducationUNKNOWN
Courtney Gallen, PhDPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents
2019. "Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03213613.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top